Your browser doesn't support javascript.
loading
Consolidation with 90Y ibritumomab tiuxetan radioimmunotherapy in mantle cell lymphoma patients ineligible for high dose therapy: results of the phase II multicentre Polish Lymphoma Research Group trial, after 8-year long follow-up.
Jurczak, Wojciech; Gruszka, Alicja M; Sowa Staszczak, Anna; Dlugosz-Danecka, Monika; Szostek, Marta; Zimowska-Curylo, Dagmara; Giza, Agnieszka; Krawczyk, Katarzyna; Jakobczyk, Malgorzata; Hubalewska-Dydejczyk, Alicja; Szymczyk, Michal; Wróbel, Tomasz; Knopinska-Posluszny, Wanda; Kisiel, Elzbieta; Skotnicki, Aleksander; Zinzani, Pier Luigi.
Afiliação
  • Jurczak W; Department of Haematology, Uniwersytet Jagiellonski w Krakowie Collegium Medicum, Krakow, Poland.
  • Gruszka AM; Department of Experimental Oncology, Istituto Europeo di Oncologia IRCCS, Milano, Italy.
  • Sowa Staszczak A; Department of Endocrinology, Nuclear Medicine Unit, Uniwersytet Jagiellonski w Krakowie Collegium Medicum, Krakow, Poland.
  • Dlugosz-Danecka M; Department of Haematology, Uniwersytet Jagiellonski w Krakowie Collegium Medicum, Krakow, Poland.
  • Szostek M; Department of Haematology, Uniwersytet Jagiellonski w Krakowie Collegium Medicum, Krakow, Poland.
  • Zimowska-Curylo D; Department of Haematology, Uniwersytet Jagiellonski w Krakowie Collegium Medicum, Krakow, Poland.
  • Giza A; Department of Haematology, Uniwersytet Jagiellonski w Krakowie Collegium Medicum, Krakow, Poland.
  • Krawczyk K; Department of Haematology, Uniwersytet Jagiellonski w Krakowie Collegium Medicum, Krakow, Poland.
  • Jakobczyk M; Department of Haematology, Uniwersytet Jagiellonski w Krakowie Collegium Medicum, Krakow, Poland.
  • Hubalewska-Dydejczyk A; Department of Endocrinology, Nuclear Medicine Unit, Uniwersytet Jagiellonski w Krakowie Collegium Medicum, Krakow, Poland.
  • Szymczyk M; Department of Lymphoid Malignancies, Centrum Onkologii-Instytut im Marii Sklodowskiej-Curie w Warszawie, Warszawa, Poland.
  • Wróbel T; Department of Haematology, Uniwersytet Medyczny im Piastow Slaskich we Wroclawiu, Wroclaw, Poland.
  • Knopinska-Posluszny W; Department of Hematology, Independent Public Health Care of the Ministry of the Internal Affairs with the Oncology Centre, Olsztyn, Poland.
  • Kisiel E; Medicover Hospital, Warsaw, Poland.
  • Skotnicki A; Department of Haematology, Uniwersytet Jagiellonski w Krakowie Collegium Medicum, Krakow, Poland.
  • Zinzani PL; Policlinico "Sant'Orsola-Malpighi" - University of Bologna Institute of Hematology "Seràgnoli", Bologna, Italy.
Leuk Lymphoma ; 60(11): 2689-2696, 2019 11.
Article em En | MEDLINE | ID: mdl-30961415
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radioisótopos de Ítrio / Radioimunoterapia / Linfoma de Célula do Manto / Anticorpos Monoclonais / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Leuk Lymphoma Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radioisótopos de Ítrio / Radioimunoterapia / Linfoma de Célula do Manto / Anticorpos Monoclonais / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Leuk Lymphoma Ano de publicação: 2019 Tipo de documento: Article